Bruno Lafont Email & Phone Number | I learned my job in Academia for 6 years in "Institut Curie", where I got all the grounds of Biochemistry, Cell culture and Phage Display. I joined Glenmark Pharmacetical company in 2007 in La-Chaux-de-Fonds (switzerland) to setup Phage Display Library expressing Fab, In 2009 I joined Novartis in Basel and still developed my competences Phage Display technology including (Yeast Display, Cell panning, affinity maturation ...) and Antibody Characterisation to make from our molecules the next drugs on the market. Since january 2023, I joined the new siRNA group to work siRNA library screening to identify lead candidates develop functional assay for chemical modification potency prediction.

Bruno Lafont

I learned my job in Academia for 6 years in "Institut Curie", where I got all the grounds of Biochem...
Mulhouse, Mulhouse, France

*50 free lookup(s) per month.

Bruno Lafont’s Phone Numbers +1 212-830-****

Get BRUNO’s Phone Number (For Free)

Social Media

Bruno Lafont’s Location Mulhouse, Mulhouse, France

Bruno Lafont’s Current Industry Novartis

Bruno Lafont’s Prior Industry Novartis Pharma | Glenmark Pharmaceuticals | Institut Curie | Centre National Du Genotypage

Find accurate emails & phone numbers for over 700M professionals.

Senior Scientist II in siRNA development

2023-01-01 00:00:00 - Present

Scientist

2009-10-01 00:00:00 - 2015-06-01 00:00:00

Research Assistant

2007-10-01 00:00:00 - 2009-09-01 00:00:00

Research Assistant

2004-09-01 00:00:00 - 2007-03-01 00:00:00

technicien

2000-01-01 00:00:00 - 2001-01-01 00:00:00

No Skills Available

No Languages Available

Bruno Lafont is a I learned my job in Academia for 6 years in "Institut Curie", where I got all the grounds of Biochemistry, Cell culture and Phage Display. I joined Glenmark Pharmacetical company in 2007 in La-Chaux-de-Fonds (switzerland) to setup Phage Display Library expressing Fab, In 2009 I joined Novartis in Basel and still developed my competences Phage Display technology including (Yeast Display, Cell panning, affinity maturation ...) and Antibody Characterisation to make from our molecules the next drugs on the market. Since january 2023, I joined the new siRNA group to work siRNA library screening to identify lead candidates develop functional assay for chemical modification potency prediction.

Bruno Lafont has prior
experience in the following industries:
Novartis Pharma | Glenmark Pharmaceuticals | Institut Curie | Centre National Du Genotypage

Bruno Lafont has the following professional experience:
Novartis | Novartis Pharma | Glenmark Pharmaceuticals | Institut Curie | Centre National Du Genotypage